A colloidal graphite-coated emitter for sheathless capillary electrophoresis/nanoelectrospray ionization mass spectrometryXIAOFENG ZHU; THIAM, Serigne; VALLE, Bertha C et al.Analytical chemistry (Washington, DC). 2002, Vol 74, Num 20, pp 5405-5409, issn 0003-2700, 5 p.Article

Effects of various CYP2D6 genotypes on the steady-state plasma concentrations of risperidone and its active metabolite, 9-hydroxyrisperidone, in Japanese patients with schizophreniaMIHARA, Kazuo; KONDO, Tsuyoshi; KANEKO, Sunao et al.Therapeutic drug monitoring. 2003, Vol 25, Num 3, pp 287-293, issn 0163-4356, 7 p.Article

Risperidone and Total 9-Hydroxyrisperidone in Relation to Prescribed Dose and Other Factors: Data From a Therapeutic Drug Monitoring Service, 2002-2010BOWSKILL, Sally V. J; HANDLEY, Simon A; FISHER, Danielle S et al.Therapeutic drug monitoring. 2012, Vol 34, Num 3, pp 349-355, issn 0163-4356, 7 p.Article

Influence of age and gender on risperidone plasma concentrationsAICHHORN, Wolfgang; WEISS, Ulrike; MARKSTEINER, Josef et al.Journal of psychopharmacology (Oxford). 2005, Vol 19, Num 4, pp 395-401, issn 0269-8811, 7 p.Article

Relationship between response to risperidone, plasma concentrations of risperidone and CYP₃A₄ polymorphisms in schizophrenia patientsDU, J; ZHANG, A; XING, Q et al.Journal of psychopharmacology (Oxford). 2010, Vol 24, Num 7, pp 1115-1120, issn 0269-8811, 6 p.Article

Risperidone and 9-hydroxyrisperidone concentrations are not dependent on age or creatinine clearance among elderly subjectsMAXWELL, Rae Ann; SWEET, Robert A; MULSANT, Benoit H et al.Journal of geriatric psychiatry and neurology. 2002, Vol 15, Num 2, pp 77-81, issn 0891-9887Article

Relationship between prolactin secretion, and plasma risperidone and 9-hydroxyrisperidone concentrations in adolescents with schizophreniform disorderDUVAL, Fabrice; GUILLON, Marie-Sabine; MOKRANI, Marie-Claude et al.Psychoneuroendocrinology. 2008, Vol 33, Num 2, pp 255-259, issn 0306-4530, 5 p.Article

ABCB1 Polymorphisms Influence Steady-State Plasma Levels of 9-Hydroxyrisperidone and Risperidone Active MoietyGUNES, Arzu; SPINA, Edoardo; DAHL, Marja-Liisa et al.Therapeutic drug monitoring. 2008, Vol 30, Num 5, pp 628-633, issn 0163-4356, 6 p.Article

Intra- and interindividual variations in steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone in schizophrenic patients treated chronically with various doses of risperidoneARAVAGIRI, Manickam; MARDER, Stephen R; NUECHTERLEIN, Keith H et al.Therapeutic drug monitoring. 2003, Vol 25, Num 6, pp 657-664, issn 0163-4356, 8 p.Article

Effect of cytochrome P450 3A4 inhibitor ketoconazole on risperidone pharmacokinetics in healthy volunteersMAHATTHANATRAKUL, W; SRIWIRIYAJAN, S; RIDTITID, W et al.Journal of clinical pharmacy and therapeutics (Print). 2012, Vol 37, Num 2, pp 221-225, issn 0269-4727, 5 p.Article

Relative Bioavailability and Pharmacokinetic Comparison of Two 2-mg Risperidone Tablet Formulations: A Single Dose, Randomized-Sequence, Double-Blind, 2-Way Crossover Study in Healthy Male Volunteers in ThailandBOONLEANG, Jutima; PIPATRATTANASEREE, Weerachai; TANTHANA, Chanpa et al.Clinical therapeutics. 2010, Vol 32, Num 10, pp 1842-1853, issn 0149-2918, 12 p.Article

Comparative Fasting Bioavailability of Dispersible and Conventional Tablets of Risperidone: A Single-Dose, Randomized-Sequence, Open-Label, Two-Period Crossover Study in Healthy Male Chinese VolunteersMINGZHU HUANG; SHEN-TU, Jianzhong; XINGJIANG HU et al.Clinical therapeutics. 2012, Vol 34, Num 6, pp 1432-1439, issn 0149-2918, 8 p.Article

Serum Levels of Risperidone and Its Metabolite, 9-Hydroxyrisperidone: Correlation Between Drug Concentration and Clinical ResponseLOSTIA, Alfonso M; MAZZARINI, Lorenzo; TATARELLI, Roberto et al.Therapeutic drug monitoring. 2009, Vol 31, Num 4, pp 475-481, issn 0163-4356, 7 p.Article

Plasma pharmacokinetic characteristics of risperidone and their relationship to saliva concentrations in children with psychiatric or neurodevelopmental disordersAMAN, Michael G; VINKS, Alexander A; REMMERIE, Bart et al.Clinical therapeutics. 2007, Vol 29, Num 7, pp 1476-1486, issn 0149-2918, 11 p.Article

Study of the complexation of risperidone and 9-hydroxyrisperidone with cyclodextrin hosts using affinity capillary electrophoresis and ¹H NMR spectroscopyDANEL, Cécile; AZAROUAL, Nathalie; BRUNEL, Albane et al.Journal of chromatography. 2008, Vol 1215, Num 1-2, pp 185-193, issn 0021-9673, 9 p.Article

Serum prolactin levels, plasma risperidone levels, polymorphism of cytochrome P450 2D6 and clinical response in patients with schizophreniaLEI WANG; LAN YU; LIN HE et al.Journal of psychopharmacology (Oxford). 2007, Vol 21, Num 8, pp 837-842, issn 0269-8811, 6 p.Article

Simultaneous determination of risperidone and 9-hydroxyrisperidone enantiomers in human blood plasma by liquid chromatography with electrochemical detectionLOCATELLI, Igor; MRHAR, Ales; GRABNAR, Iztok et al.Journal of pharmaceutical and biomedical analysis. 2009, Vol 50, Num 5, pp 905-910, issn 0731-7085, 6 p.Article

Determination of risperidone and enantiomers of 9-hydroxyrisperidone in plasma by LC-MS/MSCABOVSKA, B; COX, S. L; VINKS, A. A et al.Journal of chromatography. B. 2007, Vol 852, Num 1-2, pp 497-504, issn 1570-0232, 8 p.Article

Accuracy Profile Theory for the Validation of an LC―MS-MS Method for the Determination of Risperidone and 9-Hydroxyrisperidone in Human PlasmaXIANHUA ZHANG; XIA ZHAO; CHAO ZHANG et al.Chromatographia (Wiesbaden). 2010, Vol 71, Num 11-12, pp 1015-1023, issn 0009-5893, 9 p.Article

LC with Column-Switching and Spectrophotometric Detection for Determination of Risperidone and 9-Hydroxyrisperidone in Human SerumKIRSCHBAUM, Katrin M; FINGER, Susann; VOGEL, Friederike et al.Chromatographia (Wiesbaden). 2008, Vol 67, Num 3-4, pp 321-324, issn 0009-5893, 4 p.Article

Analysis of risperidone and its metabolite in plasma and saliva by LC with coulometric detection and a novel MEPS procedureADDOLORATA SARACINO, Maria; DE PALMA, Anna; BONCOMPAGNI, Giancarlo et al.Talanta (Oxford). 2010, Vol 81, Num 4-5, pp 1547-1553, issn 0039-9140, 7 p.Article

Pharmacodynamic consequences of P-glycoprotein-dependent pharmacokinetics of risperidone and haloperidol in miceKIRSCHBAUM, Katrin M; HENKEN, Stefanie; HIEMKE, Christoph et al.Behavioural brain research. 2008, Vol 188, Num 2, pp 298-303, issn 0166-4328, 6 p.Article

HPLC-DAD determination of plasma levels of the antipsychotic risperidone and its main metabolite for toxicological purposesRAGGI, Maria Augusta; BUGAMELLI, Francesca; SABBIONI, Cesare et al.Journal of separation science. 2005, Vol 28, Num 3, pp 245-250, issn 1615-9306, 6 p.Article

The validation of an LC-MS method for the determination of risperidone and its active metabolite 9-hydroxyrisperidone in human plasmaLI ZHANG; ZHENG JIAO; ZOUQING YAO et al.Chromatographia (Wiesbaden). 2005, Vol 61, Num 5-6, pp 245-251, issn 0009-5893, 7 p.Article

Simultaneous determination of five antipsychotic drugs in rat plasma by high performance liquid chromatography with ultraviolet detectionGUODONG ZHANG; TERRY, Alvin V; BARTLETT, Michael G et al.Journal of chromatography. B. 2007, Vol 856, Num 1-2, pp 20-28, issn 1570-0232, 9 p.Article